Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irving Kaplan

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
International Journal of Radiation Oncology, Biology, Physics|February 26, 2021
Enzalutamide With Radiation Therapy for Intermediate-Risk Prostate Cancer: A Phase 2 StudyIrving Kaplan, Glenn J Bubley, Rupal S Bhatt, et al.
Urologic Oncology|May 16, 2021
The impact of pretreatment PSA on risk stratification in men with Gleason 6 prostate cancer: Implications for active surveillanceSina Monfared, Aaron Fleishman, Ruslan Korets, et al.
Clinical Prostate Cancer|July 29, 2004
Assessing a prostate cancer brachytherapy technique using early patient-reported symptoms: a potential early indicator for technology assessment?Pearl H Seo, Anthony V D'Amico, Jack A Clark, et al.
Urologic Oncology|March 28, 2008
Bicalutamide alone prior to brachytherapy achieves cytoreduction that is similar to luteinizing hormone-releasing hormone analogues with less patient-reported morbidityJoshua H Petit, Clifford Gluck, W S Kiger, et al.
Urologic Oncology|March 21, 2022
Adjuvant chemotherapy versus observation following radical cystectomy for locally advanced urothelial carcinoma of the bladderMaheetha Bharadwaj, Sumedh Kaul, Aaron Fleishman, et al.
Prostate Cancer and Prostatic Diseases|November 26, 2022
Immediate radiotherapy versus observation in patients with node-positive prostate cancer after radical prostatectomyChristian Schaufler, Sumedh Kaul, Aaron Fleishman, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Adjuvant Chemotherapy Plus Radiotherapy versus Chemotherapy Alone for Locally Advanced Bladder Cancer after Radical CystectomyJohn Ernandez, Sumedh Kaul, Aaron Fleishman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 25, 2013
Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trialsChristopher R King, Debra Freeman, Irving Kaplan, et al.
Urologic Oncology|December 5, 2022
Urothelial carcinoma of the bladder with isolated lymph node metastasis: Natural history and outcomes following surgical resectionErnest Morton, Sumedh Kaul, Aaron Fleishman, et al.
The Prostate|December 2, 2023
Adjuvant and salvage radiotherapy after neoadjuvant therapy and radical prostatectomy for high-risk localized prostate cancerPraful Ravi, Lucia Kwak, Wout Devlies, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
International Journal of Radiation Oncology, Biology, Physics|February 26, 2021
Enzalutamide With Radiation Therapy for Intermediate-Risk Prostate Cancer: A Phase 2 StudyIrving Kaplan, Glenn J Bubley, Rupal S Bhatt, et al.
Urologic Oncology|May 16, 2021
The impact of pretreatment PSA on risk stratification in men with Gleason 6 prostate cancer: Implications for active surveillanceSina Monfared, Aaron Fleishman, Ruslan Korets, et al.
Clinical Prostate Cancer|July 29, 2004
Assessing a prostate cancer brachytherapy technique using early patient-reported symptoms: a potential early indicator for technology assessment?Pearl H Seo, Anthony V D'Amico, Jack A Clark, et al.
Urologic Oncology|March 28, 2008
Bicalutamide alone prior to brachytherapy achieves cytoreduction that is similar to luteinizing hormone-releasing hormone analogues with less patient-reported morbidityJoshua H Petit, Clifford Gluck, W S Kiger, et al.
Urologic Oncology|March 21, 2022
Adjuvant chemotherapy versus observation following radical cystectomy for locally advanced urothelial carcinoma of the bladderMaheetha Bharadwaj, Sumedh Kaul, Aaron Fleishman, et al.
Prostate Cancer and Prostatic Diseases|November 26, 2022
Immediate radiotherapy versus observation in patients with node-positive prostate cancer after radical prostatectomyChristian Schaufler, Sumedh Kaul, Aaron Fleishman, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Adjuvant Chemotherapy Plus Radiotherapy versus Chemotherapy Alone for Locally Advanced Bladder Cancer after Radical CystectomyJohn Ernandez, Sumedh Kaul, Aaron Fleishman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 25, 2013
Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trialsChristopher R King, Debra Freeman, Irving Kaplan, et al.
Urologic Oncology|December 5, 2022
Urothelial carcinoma of the bladder with isolated lymph node metastasis: Natural history and outcomes following surgical resectionErnest Morton, Sumedh Kaul, Aaron Fleishman, et al.
The Prostate|December 2, 2023
Adjuvant and salvage radiotherapy after neoadjuvant therapy and radical prostatectomy for high-risk localized prostate cancerPraful Ravi, Lucia Kwak, Wout Devlies, et al.
Pageof 4